Arbutus Biopharma Corporation
DE ˙ DB ˙ CA03879J1003
3,73 € ↑0,06 (1,63%)
2026-06-04
DEL PRIS
SecurityDE:I9DN / Arbutus Biopharma Corporation
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership3,771,806 shares
Latest Disclosed Value $ 16,976,722
Geode Capital Management, Llc reports 2.57% increase in ownership of I9DN / Arbutus Biopharma Corporation

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 3,771,806 shares of Arbutus Biopharma Corporation (DE:I9DN) valued at $13,834,984 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 3,677,307 shares of Arbutus Biopharma Corporation. This represents a change in shares of 2.57% during the quarter. The current value of the position is $14,068,836 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 3,771,806 94,499 2.57 16,977 -4.04 0.0006
2026-02-09 2025-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 3,677,307 11,145 0.30 17,691 6.27 0.0011
2025-11-12 2025-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 3,666,162 29,141 0.80 16,648 48.10 0.0011
2025-08-08 2025-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 3,637,021 95,876 2.71 11,240 -9.08 0.0008
2025-05-13 2025-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 3,541,145 59,009 1.69 12,362 8.54 0.0010
2025-02-12 2024-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 3,482,136 33,536 0.97 11,390 -14.24 0.0009
2024-11-12 2024-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 3,448,600 135,442 4.09 13,280 29.69 0.0011
2024-08-09 2024-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 3,313,158 354,271 11.97 10,240 34.14 0.0009
2024-05-13 2024-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 2,958,887 141,192 5.01 7,635 8.38 0.0007
2024-02-13 2023-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 2,817,695 120,611 4.47 7,045 28.66 0.0007
2023-11-13 2023-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 2,697,084 98,958 3.81 5,476 -8.37 0.0007
2023-08-11 2023-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 2,598,126 310,213 13.56 5,976 -13.81 0.0007
2023-05-15 2023-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 2,287,913 156,645 7.35 6,932 173,200.00 0.0009
2023-02-13 2022-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 2,131,268 121,428 6.04 5 -99.90 0.0007
2022-11-14 2022-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 2,009,840 224,798 12.59 3,838 -20.65 0.0006
2022-08-12 2022-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 1,785,042 55,064 3.18 4,837 -6.17 0.0007
2022-05-13 2022-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 1,729,978 60,354 3.61 5,155 -20.62 0.0006
2022-02-11 2021-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 1,669,624 129,193 8.39 6,494 -1.73 0.0008
2021-11-12 2021-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 1,540,431 253,773 19.72 6,608 69.52 0.0009
2021-08-13 2021-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 1,286,658 752,076 140.68 3,898 118.99 0.0005
2021-05-12 2021-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 534,582 132,931 33.10 1,780 24.91 0.0003
2021-02-12 2020-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 401,651 21,274 5.59 1,425 19.75 0.0002
2020-11-13 2020-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 380,377 67,347 21.51 1,190 109.14 0.0002
2020-08-13 2020-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 313,030 204,634 188.78 569 422.02 0.0001
2020-05-14 2020-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 108,396 -19,117 -14.99 109 -69.21 0.0000
2020-02-20 2019-12-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 127,513 52,387 69.73 354 210.53 0.0001
2020-02-13 2019-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 127,513 52,387 354 45.1142
2019-11-12 2019-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 75,126 -1,569 -2.05 114 -28.30 0.0000
2019-08-14 2019-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 76,695 -186,295 -70.84 159 -83.10 0.0000
2019-05-14 2019-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 262,990 27,058 11.47 941 4.21 0.0002
2019-03-06 2018-12-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 235,932 51,127 27.67 903 -48.28 0.0003
2019-02-13 2018-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 235,932 51,127 903
2018-11-13 2018-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 184,805 61,017 49.29 1,746 93.36 0.0005
2018-08-14 2018-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 123,788 109,520 767.59 903 1,171.83 0.0003
2018-05-15 2018-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 14,268 0 0.00 71 -1.39 0.0000
2018-02-13 2017-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 14,268 -12,847 -47.38 72 -57.14 0.0000
2017-11-14 2017-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 27,115 0 0.00 168 73.20 0.0001
2017-08-14 2017-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 27,115 -378 -1.37 97 8.99 0.0000
2017-06-21 2017-03-31 13F/A-1 ARBUTUS BIOPHARMA COM 03879J100 27,493 858 3.22 89 36.92 0.0000
2017-05-12 2017-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 27,493 89
2017-02-14 2016-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 26,635 572 2.19 65 -26.97 0.0000
2016-11-10 2016-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 26,063 143 0.55 89 -1.11 0.0000
2016-08-12 2016-06-30 13F ARBUTUS BIOPHARMA COM 03879J100 25,920 5,717 28.30 90 8.43 0.0000
2016-05-13 2016-03-31 13F ARBUTUS BIOPHARMA COM 03879J100 20,203 -143 -0.70 83 -7.78 0.0000
2016-02-12 2015-12-31 13F ARBUTUS BIOPHARMA COM 03879J100 20,346 286 1.43 90 -26.23 0.0001
2015-11-13 2015-09-30 13F ARBUTUS BIOPHARMA COM 03879J100 20,060 20,060 122 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.